Your browser doesn't support javascript.
loading
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors.
Cho, Byoung Chul; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Cho, Eun Kyung; Lee, Yun-Gyoo; Kim, Dong-Wan; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok; Shim, Byoung Yong; Kim, Jin-Soo; Chun, Sang Hoon; Lee, Sung Sook; Kim, Hye Ryun; Hong, Min Hee; Ahn, Jin Seok; Sun, Jong-Mu; Lee, Youngjoo; Lee, Dae Ho; Kang, Ji Ah; Lee, NaMi; Kwon, Mi-Jung; Espenschied, Carin; Yablonovitch, Arielle; Ahn, Myung-Ju.
Affiliation
  • Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Han JY; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee KH; Division of Medical Oncology, Department of Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
  • Cho EK; Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim JH; CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Lee GW; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University, College of Medicine, Seongnam, Republic of Korea.
  • Shim BY; Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Republic of Korea.
  • Kim JS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Chun SH; Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, Republic of Korea.
  • Lee SS; Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
  • Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Lee Y; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Lee DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kang JA; Clinical Development Department, Yuhan Corporation, Seoul, Republic of Korea.
  • Lee N; Clinical Development Department, Yuhan Corporation, Seoul, Republic of Korea.
  • Kwon MJ; Clinical Development Department, Yuhan Corporation, Seoul, Republic of Korea.
  • Espenschied C; Guardant Health, Inc., Redwood City, California.
  • Yablonovitch A; Guardant Health, Inc., Redwood City, California.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea. Electronic address: silkahn@skku.edu.
J Thorac Oncol ; 17(4): 558-567, 2022 04.
Article in En | MEDLINE | ID: mdl-34958928
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Adult / Humans Language: En Journal: J Thorac Oncol Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Adult / Humans Language: En Journal: J Thorac Oncol Year: 2022 Type: Article